Strategic and results-oriented biotechnology CEO with proven track record of leadership and execution

Over twenty-five years of executive and scientific experience building teams, raising capital and advancing programs from research through product development towards commercialization

As CEO of Cellerant Therapeutics, Dr. Mandalam led the development of a pipeline of candidates for the treatment of hematological malignancies rapidly advancing the lead program to late clinical stage, established a regulatory strategy for product approval and obtained RMAT designation for the lead program 

As executive director of product development at Geron Corporation, managed the development and manufacturing of off-the-shelf pluripotent stem cell-based therapies for the treatment of degenerative diseases and cancer

Held various positions in Research and Development at Aastrom Biosciences

Serves on the Boards of Cryoport, Inc and Stempeutics Research Pvt. Ltd. 

Author/co-author of several publications, patent applications and abstracts